Related Experiment Video
Updated: Aug 9, 2026
10:16
Generating Genetically Modified Plasmodium berghei Sporozoites
Published on: May 5, 2023
Proteasome inhibitors block development of Plasmodium spp
S M Gantt1, J M Myung, M R Briones
1Department of Pathology, NYU Medical Center, New York, New York 10016, USA.
Antimicrobial Agents and Chemotherapy
|October 3, 1998
Summary
Proteasome inhibitors like lactacystin can halt the development of malaria parasites, including Plasmodium falciparum. This research suggests proteasome inhibition as a potential strategy for treating protozoan parasitic diseases.
Area of Science:
- Molecular Biology
- Parasitology
- Drug Discovery
Background:
- Proteasomes are crucial for degrading proteins in eukaryotic cells, regulating vital processes like cell cycle progression.
- Protozoan parasites, responsible for diseases like malaria, possess proteasome activity essential for their lifecycle.
- Targeting essential cellular machinery in parasites offers a promising avenue for novel therapeutic development.
Purpose of the Study:
- To investigate the effect of lactacystin, a specific 20S proteasome inhibitor, on the developmental stages of the malaria parasite.
- To determine the cell cycle specificity of lactacystin's inhibitory action on Plasmodium parasites.
- To evaluate the potential of proteasome inhibitors as therapeutic agents against protozoan parasitic infections.
Main Methods:
- Treatment of Plasmodium berghei and Plasmodium falciparum with nanomolar concentrations of lactacystin.
- In vitro and in vivo assays to assess parasite development, including sporozoite invasion and exoerythrocytic form (EEF) development.
- Synchronization of erythrocytic stages and assessment of drug treatment timing relative to DNA synthesis.
- Evaluation of parasitemia reduction in infected rats.
Main Results:
- Lactacystin, at nanomolar concentrations, significantly inhibited the development of exoerythrocytic and erythrocytic stages of malaria parasites.
- Lactacystin-treated Plasmodium berghei sporozoites remained invasive but failed to develop into EEFs.
- Inhibition of Plasmodium falciparum erythrocytic schizogony was observed when drug treatment preceded DNA synthesis, indicating cell cycle specificity.
- Lactacystin reduced parasitemia in rats, but the therapeutic index was found to be very low.
Conclusions:
- Proteasome inhibition by lactacystin effectively disrupts critical developmental stages of malaria parasites.
- The cell cycle-specific inhibitory effect suggests targeted intervention points within the parasite lifecycle.
- These findings underscore the potential of proteasome inhibitors as a novel class of drugs for treating protozoan parasitic diseases, including malaria.
- Further research is warranted to optimize proteasome inhibitor-based therapies and improve their therapeutic index.
More Related Videos
Related Concept Videos
01:27Diversity of Protists II
Alveolates are a group of organisms recognized by the presence of alveoli, which are cytoplasmic sacs located beneath the cell membrane. While their function remains uncertain, alveoli may help regulate water balance by controlling how much water enters and leaves the cell. In dinoflagellates, these structures may serve as armor plates. There are three major types of alveolates: ciliates, which move using cilia; dinoflagellates, which use flagella for movement; and apicomplexans, which are...
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...